Nalmefene Hydrochloride

盐酸纳美芬

Report date: 2026/05/24 20:00:34
NME

Base Information

Drug NameNalmefene Hydrochloride
Drug Alias Name纳美芬Nalmetrene纳美芬盐酸盐nalmefenumnalmefeno +[22] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOpioid receptors antagonists
TargetsOpioid receptors
Therapy Area/IndicationsCNS Embryonal TumorGamblingSmoking Cessation +[13] 
Global Approved IndicationsAlcoholismAlcohol-Related DisordersSubstance-Related Disorders +[4] 
Approved Indications in ChinaSubstance-Related Disorders
Original Approved Country/TerritoryUnited States
Original Approved Date1995/04/17
Country/TerritoryCzechiaBelgiumUnited States +[23] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBaxter International Inc
China Registration ClassN/A

Develop Information

Active CompaniesTharimmune IncOtsuka Holdings Co LtdNational Institute On Alcohol Abuse And Alcoholism +[5] 
Inactive CompaniesHikmaReacx Pharmaceuticals IncOpiant Pharmaceuticals Inc +[11] 
Active IndicationsOpioid-Related DisordersDrug OverdoseAlcoholism +[7] 
Inactive IndicationsCNS Embryonal TumorGamblingSmoking Cessation +[6] 

Other Information

ATC CodeN07BB05
Related LinksWikipediaKEGG